KOL ID is used to identify highly qualified KOLs who are best suited to support the clinical and commercial development of a new or existing product or indication. The goal is to prioritize these KOLs for engagement in advisory board meetings, publications, speaker programs, clinical research or regulatory meetings.
KOL ID begins with a development plan, which specifies activities that will benefit from KOL participation as well as the qualifications required to support each activity. We evaluate background information, and use a customized algorithm to weight qualifications to generate a prioritized list of KOL nominees. In collaboration with you, a final prioritized list of KOLs is created for each activity.
The four key steps of the KOL ID process are: